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Abstract
Introduction The present study established characteristics of
tissue regrowth in patients suffering knee lesions treated with
grafts of autologous chondrocytes grown on three-dimensional
hyaluronic acid biomaterials.
Methods This multicentred study involved a second-look
arthroscopy/biopsy, 5 to 33 months post implant (n = 63).
Seven patients allowed a third-look biopsy, three of which were
performed 18 months post implant. Characteristics of tissues
were histologically and histochemically evaluated. The
remaining bone stubs were evaluated for cartilage/bone
integration. For data analysis, biopsies were further divided into
those obtained from postoperative symptomatic patients (n =
41) or from asymptomatic patients (n = 22).
Results The percentage of hyaline regenerated tissues was
significantly greater in biopsies obtained after, versus within, 18
months of implantation. Differences were also observed
between symptomatic and asymptomatic patients: reparative
tissues taken from symptomatic patients 18 months after
grafting were mainly fibrocartilage or mixed
(hyaline–fibrocartilage) tissue, while tissues taken from
asymptomatic patients were hyaline cartilage in 83% of
biopsies. In a small group of asymptomatic patients (n = 3),
second-look and third-look biopsies taken 18 months after
surgery confirmed maturation of the newly formed tissue over
time. Cartilage maturation occurred from the inner regions of the
graft, in contact with subchondral bone, towards the periphery
of the implant.
Conclusions The study indicates that, in asymptomatic patients
after chondrocyte implantation, regenerated tissue undergoes a
process of maturation that in the majority of cases takes longer
than 18 months for completion and leads to hyaline tissue and
not fibrous cartilage. Persistence of symptoms might reflect the
presence of a nonhyaline cartilage repair tissue.
Introduction
Full-thickness cartilage defects do not heal spontaneously.
Lesions that penetrate the subchondral bone undergo repair
with fibrocartilage, a tissue that resists tension but not com-
pression [1,2]. Current therapies, such as transplantation of
healthy cartilage, microfracture of the subchondral bone plate
and implantation of artificial polymers or metal prostheses,
have many limitations [3,4]. In past decades, investigators
have pursued techniques for stimulating articular repair and
regeneration. In particular, autologous chondrocyte implanta-
tion is a promising cell therapy technique [5-8] – yet it is lim-
ited by the complexity of the surgical procedure required for
periosteal harvesting and by its associated morbidity.
A more recent approach to treating cartilage defects is the use
of  in vitro engineered tissue obtained using autologous
chondrocytes seeded and cultured onto biodegradable and
biocompatible scaffolds. Three-dimensional biodegradable
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materials derived from the total esterification of hyaluronan
with benzyl alcohol and constructed with a nonwoven config-
uration (Hyaff-11) have been successfully utilized for culturing
autologous chondrocytes [9-12]. Human articular chondro-
cytes derived from knee articular biopsies and cultured as a
monolayer de-differentiate after a few days of cell expansion,
but a three-dimensional environment promotes re-differentia-
tion to the cartilage phenotype. RNA analysis and immunohis-
tochemistry reveal that cells sustain the expression of cartilage
genes and proteins, such as collagen type II, type IX, and type
X, aggrecan and sox 9 [13,14]. Clinical medium-term results
on the treatment of 0.5 to 15 cm2 defects with tissue engi-
neered grafts made ofautologous chondrocytes grown on
Hyaff 11 (Hyalograft® C Autograft; Fidia Advanced Biopoly-
mers, Abano Terme, Italy) were very favourable, with more than
90% of patients expressing an improvement in knee symptoms
and function and a very limited number of complications
[15,16]. The Hyalograft® C Autograft was simply placed into
the prepared lesion, where it was stable and without the need
for any fixation method. The extent of tissue regeneration after
Hyalograft® C Autograft implantation was also studied in 23
patients using a new quantitative analysis of collagen type II
that distinguishes hyaline cartilage from the type I collagen
found predominantly in fibrocartilage [17,18]. In that study, tis-
sue engineered grafts induced cartilage regeneration as early
as 11 months after implantation, and integration of the newly
formed tissues with underlying bone was good in all patients.
In the present study, we analysed 70 biopsies, 63 second-look
biopsies and seven third-look biopsies, taken from patients 5
to 33 months after Hyalograft® C Autograft implantation for
cartilage lesions of the knee. Biopsies were divided between
symptomatic and asymptomatic patients to identify the rela-
tionship between reconstructive success and histological
composition of the new tissue. The analysis of cartilage matu-
ration 18 months post implant in the same individual, however,
was only possible in three patients.
Materials and methods
Patients
The samples analysed were from a series of consecutive biop-
sies received at our laboratory from 63 patients with knee car-
tilage lesions treated with Hyalograft® C Autograft at 11 Italian
orthopaedic centres. For each centre, the local ethical commit-
tee approved the study; after informed consent, biopsies were
sampled from patients at the time of their follow-up arthros-
copy. Patients' sole inclusion criterion into the study was their
written informed consent to undergo a biopsy at the time of
arthroscopy. No exclusion criteria were applied.
Tissue engineering and the Hyalograft® C surgical 
technique
The Hyalograft® C Autograft is a tissue graft consisting of
autologous chondrocytes grown on a three-dimensional scaf-
fold made of hyaluronic acid, used in clinical practice since
1999 for the treatment of full-thickness cartilage defects. It is
obtained by seeding autologous chondrocytes into a three-
dimensional biodegradable material derived from the total
esterification of hyaluronan with benzyl alcohol and con-
structed with a non-woven configuration (Hyaff 11). Briefly,
cells were obtained from the digestion of biopsies as
described elsewhere [11], were re-suspended in DMEM
medium, and were seeded and cultured onto the Hyaff 11
scaffold for 14 days.
In the majority of cases, the Hyalograft® C Autograft was posi-
tioned at the lesion site by a mini-arthrotomy using a simple
procedure. In the case of large uncontained defects, particu-
larly in the patello-femoral compartment, fibrin glue and/or
sutures were used to keep the graft in place. Subsequent
immobilization was recommended for 12 to 24 hours post
grafting.
Second-look and third-look biopsy harvesting
Seventy biopsies from 63 patients treated with tissue-engi-
neered cartilage were analysed. All patients had the second-
look biopsy at the time of their follow-up arthroscopy, and
seven patients permitted a third-look biopsy at the time of their
second arthroscopy. These subsequent biopsies were taken
presumably from the same location. The biopsies (2 mm diam-
eter) were taken primarily (n = 62) from the medial or lateral
condyle; others were taken from the tibial plate (n = 2), troch-
lea (n = 1) or patella (n = 5).
Histological evaluation
Full-thickness cylindrical biopsies with a 2 mm diameter
extending from the articular surface to the subchondral bone
were obtained from the centre of the defect, were embedded
in optimal cutting temperature (OCT) embedding medium,
were snap-frozen and were cut into 7 μm sections. Cellular
and histochemical characteristics of the repair tissue were
evaluated histologically and immunohistochemically.
For routine histology, specimens were stained with H & E to
visualize the cellularity, the morphology of cells and the matrix
appearance of the repair tissue. Safranin-O stain was used to
detect the presence of glycosaminoglycans. Specimens were
also analysed using polarized light microscopy to examine col-
lagen organization in the tissue extracellular matrix.
For immunohistological analysis with specific antibodies –
monoclonal collagen I antibody (Sigma, St Louis, MO, USA)
and monoclonal anti-collagen II antibody (Developmental
Studies Hybridoma Bank, Iowa City, IA, USA) – frozen sec-
tions were fixed in acetone, were predigested with hyaluroni-
dase (to expose collagen epitopes to antibodies) and were
subsequently incubated in Tris buffer saline (10 mM Tris, 150
mM NaCl, pH 7.4) containing 10% normal rabbit serum (Dako,
Glostrup, Denmark), primary antibody and secondary rabbit
anti-mouse antibody (Dako), and were finally treated with anAvailable online http://arthritis-research.com/content/10/6/R132
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alkaline phosphatise-antialkaline phosphatise (APAAP) com-
plex (Dako) and stained with fast red (Sigma).
Human placenta was used as a positive control for collagen
type I, and healthy articular cartilage for collagen type II. Neg-
ative control slides were obtained by treating specimens with
mouse monoclonal IgG1 or mouse monoclonal IgM (Dako).
The positive red reaction for collagens obtained with immuno-
histochemistry was classified as very intense, intense, slight or
absent.
Repair tissue was evaluated with specific histological criteria
regarding cellularity, the cell distribution and the matrix compo-
sition in hyaline tissue, fibrocartilage and mixed tissues. Two
investigators scored each biopsy under blind conditions, and
classified them: as hyaline-like cartilage when round cells in
lacunae were in clusters and columns, and collagen fibrils,
mainly of type II collagen (very intense), were parallel to the
surface; as fibrocartilage when cells with rounded morphology
and collagen type I fibrils (very intense) were localized ran-
domly; or as mixed tissues when hyaline-like tissue and fibro-
cartilage-like tissue were present, with a moderate content of
collagen type II (intense).
The biopsies were divided into two groups considering the
time from implantation: biopsies taken within 18 months of
Hyalograft®  C Autograft implantation, and biopsies taken
longer than 18 months after surgery.
Analysis of tidemark
The degree of integration of implanted tissue to bone was ana-
lysed by the presence of a tidemark; that is, the calcified inter-
face between cartilage and bone where the tissues have
become mineralized. This analysis was only performed on
samples containing subchondral bone (21 cases). In such
cases, the bone was separated from the overlying cartilage,
decalcified and placed in paraffin. The samples then under-
went histological analysis (H & E) to assess the degree of inte-
gration between the newly formed cartilage and the underlying
bone surface.
Stained sections were independently scored by three investi-
gators, blinded to the treatment outcome, each describing the
histological appearance under light microscopy (Zeiss,
Oberkochen, Germany). The presence of a tidemark (yes or
no) was also evaluated.
Statistical analyses
The Fisher exact test was used to compare the morphology of
regenerated tissues between the two treated groups of
patients (biopsies obtained longer than 18 months after sur-
gery and biopsies obtained within 18 months of surgery). P <
0.05 was considered significant. No intrapatient analysis of
results over time was performed due to the small number of
patients (n = 3) for whom this comparison was appropriate.
Results
Patients
Baseline clinical data are presented in Table 1. Seventy biop-
sies from 63 patients treated with tissue-engineered cartilage
were analysed. Of these, 47 biopsies (67.1%) were harvested
from asymptomatic patients who had agreed to biopsy har-
vesting, despite the fact that they no longer suffered symp-
toms. The other biopsies (n = 23, 32.9%) were from
symptomatic patients who were biopsied for a wide variability
of clinical reasons, such as knee pain, fibrillation, gonalgia,
swelling or other symptoms. There were 22 patients who
reported symptoms (34.9%; one of them had a third-look
biopsy) and 41 patients who had no symptom at all (65.1%;
six of them had a third-look biopsy).
The patient cohort included 41 men and 22 women with a
mean age of 39 years (standard deviation = 11.47; minimum
age = 16 years, maximum age = 64 years). The mean follow-
up time between the application of Hyalograft®C and the
biopsy was 14.1 months (minimum time = 5 months, maximum
Table 1
Characteristics of patients (n = 63) suffering knee lesions who 
were treated with a tissue engineered graft made with 
autologous chondrocytes grown on a three-dimensional 
hyaluronic acid-based biomaterial
Characteristic Baseline
Age (years)
 Mean (standard deviation) 39 (11.47)
 Range (minimum to maximum) 16 to 64
Gender (male/female) 41/22
Biopsies from asymptomatic patients 23 biopsies
Biopsies from asymptomatic patients 47 biopsies
Single lesion 39 patients
Multiple lesions 31 patients
Location of defect
 Medial or lateral condyle 62 biopsies
 Tibial plateau 2 biopsies
 Trochlea 1 biopsy
 Patella 5 biopsies
Total surface area for all patients (mean (standard 
deviation))
 Range in asymptomatic patients (cm2)5 . 2  ( 2 . 9 )
 Range in symptomatic patients (cm2)3 . 4  ( 2 . 8 )
Outerbridge grade
 Outerbridge grade IV 57 patients
 Outerbridge grade III 6 patients
Biopsies (n = 70) were classified by their time after implantation: 
before 18 months of follow-up or after longer than 18 months of 
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time = 33 months). The mean lesion area in treated asympto-
matic patients (5.2 cm2, standard deviation = 2.9) was greater
than the lesion area of symptomatic patients (3.4 cm2, stand-
ard deviation = 2.8) (see Table 1).
Histological and immunohistochemical analysis
When all biopsies were grouped together (n = 70), histology
showed that 19 biopsies (27.2%) were composed of tissue
with a typical hyaline cartilage cell distribution in clusters and
columns in the lacunae (Figure 1a,b); that 36 biopsies
(51.4%) demonstrated cells with rounded morphology that
were localized randomly, as in fibrocartilage (Figure 2a,b); and
that 15 biopsies (21.4%) demonstrated a mixed-type tissue
(hyaline-like and fibrocartilage-like tissue) (Figure 3a,b). Histo-
chemical analysis revealed that collagen type II was more
expressed in hyaline tissue (very intense), whereas collagen
type I was predominant in fibrocartilage (very intense) (Figures
1c,d, 2c,d and 3c,d).
These data were confirmed by analyses of biopsies with polar-
ized microscopy, which demonstrated the presence of typical
hyaline collagen fibrils parallel to the surface of the biopsy with
a normal cartilage cell organization. In contrast, biopsies with
an abnormal cartilage cell distribution had randomly oriented
collagen fibrils, typical of fibrocartilage (Figures 1e, 2e and
3e). In 21 samples, it was also possible to analyse the inter-
face between cartilage and subchondral bone. H & E analysis
at their interface showed that all grafted cartilage was well
integrated, regardless of whether it was hyaline, fibrocartilage
or mixed. Furthermore, a tidemark typical of native cartilage
was observed in all biopsies classified as hyaline cartilage
(Figure 4).
The biopsies were then divided into two groups: biopsies
obtained within 18 months from Hyalograft®  C Autograft
implantation, and biopsies obtained longer than 18 months
after surgery. The biopsies taken after a longer follow-up
period showed a higher percentage of hyaline cartilage
(45.4% hyaline cartilage versus 23.7% in biopsies taken
within the first 18 months). Fibrocartilage was present in
55.9% of biopsies taken within 18 months after implantation
and in 27.3% of those taken after that period. Mixed tissue
was present in 20.3% of biopsies taken within 18 months after
implantation and in 27.3% of those taken after that period (Fig-
ure 5).
When biopsies were limited to those from asymptomatic
patients taken longer than 18 months after grafting (n = 6), the
Figure 1
Histological and immunohistochemical analysis of a second-look cartilage biopsy with hyaline characteristics Histological and immunohistochemical analysis of a second-look cartilage biopsy with hyaline characteristics. Analysis of a second-look cartilage 
biopsy with hyaline characteristics taken 14 months after Hyalograft® C Autograft implantation. (a) H & E and eosin staining. (b) Glycosaminoglycan 
(safranin-O) staining. (c) Collagen type I (immunohistochemistry). (d) Collagen type II (immunohistochemistry). (e) Polarized light microscopy.Available online http://arthritis-research.com/content/10/6/R132
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percentage of samples with predominantly hyaline cartilage
increased to 83% (Figure 6). Using the Fisher exact test, hya-
line tissue was present in significantly greater quantities in
biopsies taken longer than 18 months from grafting (P  =
0.0042).
In biopsies of symptomatic patients taken longer than 18
months after grafting (n = 5), reparative tissue was fibrocarti-
lage (60%) or mixed tissue (40%).
When biopsies were limited to only those from asymptomatic
patients who had received both second-look and third-look
biopsies (n = 3), with the third-look biopsies taken longer than
18 months after surgery, we observed clear evidence of carti-
lage maturation over time. In fact, analysis of these same
patients at the second-look biopsies (mean time from implan-
tation = 13.6 months) showed fibrocartilage, mixed tissue and
hyaline tissue, while the third-look biopsies (mean time from
implantation = 30.6 months) were all hyaline cartilage.
In most of the specimens classified as mixed, we observed
that the direction of maturation was bottom-up. In the inner
region of the implant, in contact with the subcondral bone, we
noted a hyaline-like tissue; proceeding toward the edges, the
regenerated tissue was mostly fibrocartilage (Figure 7), con-
firmed by analysis of the type I collagen content (data not
shown).
Discussion
In the present study, Hyalograft® C Autografts were implanted
for the treatment of cartilage lesions. As previous studies had
already demonstrated [18], the clinical outcome of Hyalo-
graft® C Autograft implantation is as good as and comparable
with results obtained with autologous chondrocyte implanta-
tion (ACI). This technique does not involve open surgery and
thus markedly reduces joint trauma compared with ACI. More-
over, in the majority of cases, implantation is stable and does
not require any fixation method because of the intrinsic adhe-
sive properties of the hyaluronan scaffold. Consequently, there
is no need to harvest a periosteal flap. Other studies have
demonstrated that cartilage tissue regeneration after surgery
with Hyalograft® C Autograft leads to good results in terms of
collagen composition and integration with the subchondral
bone [17]. In the present study, the interface between new
generated cartilage and subchondral bone was always well
integrated, regardless of whether it was hyaline tissue, fibro-
cartilage or mixed-type tissue.
Figure 2
Histological and immunohistochemical analysis of a second-look cartilage biopsy with fibrocartilage characteristics Histological and immunohistochemical analysis of a second-look cartilage biopsy with fibrocartilage characteristics. Analysis of a second-look carti-
lage biopsy with fibrocartilage characteristics taken 10 months after Hyalograft® C Autograft implantation. (a) H & E staining. (b) Glycosaminoglycan 
(safranin-O) staining. (c) Collagen type I (immunohistochemistry). (d) Collagen type II (immunohistochemistry). (e) Polarized light microscopy.Arthritis Research & Therapy    Vol 10 No 6    Brun et al.
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Characterization of cartilage maturation after Hyalograft® C
Autograft implantation demonstrated that cartilage regenera-
tion was a slow process that, in most cases, took longer than
18 months. The most important result of the present study was
that the percentage of hyaline cartilage was greater in biopsies
obtained longer than 18 months after implantation rather than
within 18 months of implantation. Moreover, we noted a corre-
lation between the symptomatology of patients and the nature
of the reparative tissue. Asymptomatic patients developed pre-
dominantly hyaline tissue in a highly significant percentage of
cases, while symptomatic patients presented fibrocartilage or
mixed tissue.
These results were confirmed in the small subgroup of three
asymptomatic patients who received both second-look and
third-look biopsies, with the third-look biopsies taken longer
than 18 months after surgery: there was clear evidence of car-
tilage maturation over time. Second-look biopsies showed
fibrocartilage, hyaline tissue or mixed tissue, while third-look
biopsies derived from the same patients were all hyaline tis-
sue. The patient number is very limited because patients with
a good clinical outcome rarely consent to additional biopsies.
With regard to the direction of tissue regeneration over time,
histological observation of specimens demonstrated that, in
Figure 3
Histological and immunohistochemical analysis of a second-look cartilage biopsy with mixed (hyaline and fibrocartilage) characteristics Histological and immunohistochemical analysis of a second-look cartilage biopsy with mixed (hyaline and fibrocartilage) characteristics. Analysis of a 
second-look cartilage biopsy with mixed characteristics taken 10 months after Hyalograft® C Autograft implantation. (a) H & E staining. (b) Gly-
cosaminoglycan (safranin-O staining). (c) Collagen type I (immunohistochemistry). (d) Collagen type II (immunohistochemistry). (e) Polarized light 
microscopy.
Figure 4
Tide mark evidence for repair tissue Tide mark evidence for repair tissue. Tidemark evidence from a patient 
with hyaline repair tissue 12 months after implantation of the 
Hyalograft® C Autograft. Blue arrow, surface direction.Available online http://arthritis-research.com/content/10/6/R132
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most mixed tissue, regeneration occurred first in contact with
the subchondral bone and then proceeded toward the outer
region. Soon after grafting, chondrocytes are known to prolif-
erate and to synthesize extracellular matrix cartilage with a
poor molecular network rich in collagen type I – leading to the
formation of immature tissue that, in time, differentiates and
becomes organized into hyaline tissue with cells in columns
immersed in a specialized extracellular matrix rich in collagen
type II. The present data indicate that cartilage regeneration
might resemble tissue formation during embryogenesis, even
if tissue strategies are different from early embryonic events.
Previous studies have demonstrated the plasticity of mature
chondrocytes and how they de-differentiate towards the phe-
notypical characteristics of immature chondrocytes when cul-
tured in two dimensions [19]. Other studies have revealed that
environmental conditions are very important for cell re-differen-
tiation, and it is well known that the biochemical and physical
factors act in concert with genes to mediate their expression
[20]. The chemical composition of scaffolds can also be
inductive for cell proliferation [21] or for differentiation in
adults. In fact, the presence of hyaluronic acid plays an impor-
tant role in cartilage differentiation, as demonstrated in the
embryo [22,23].
From our analysis of second-look and third-look cartilage biop-
sies from patients with cartilage lesions treated with Hyalo-
graft® C Autograft, we can state that the plasticity of mature
chondrocytes is sufficient to enable de-differentiated cells to
revert to differentiation. For this reason, mature cells can be
used in in vitro cartilage tissue reconstruction with impressive
results in terms of grafting and clinical outcome. In the three
asymptomatic patients who received both second-look and
third-look biopsies, with the last biopsy taken 18 months after
surgery, cartilage maturation was shown to improve with time.
We can therefore affirm that cartilage regeneration is a long
process usually taking more than 18 months to be completed.
Figure 5
Histological and immunohistochemical analysis data for biopsies  obtained before or after 18 months post implantation Histological and immunohistochemical analysis data for biopsies 
obtained before or after 18 months post implantation. Data obtained 
from histological and immunohistochemical analyses of the biopsies 
were divided into two groups: biopsies taken before (n = 59) or after (n 
= 11) the cutoff point of 18 months post Hyalograft® C Autograft 
implantation. Only 23.7% of specimens (n = 59) obtained from patients 
before 18 months showed characteristics of hyaline cartilage, whereas 
45.4% of specimens (n = 11) taken after more than 18 months were of 
hyaline cartilage. Fibrocartilage was present in 55.9% of biopsies taken 
before 18 months and in 27.3% of those taken after more than 18 
months. Similarly, mixed tissue was present in 20.3% of biopsies taken 
before 18 months and in 27.3% of those taken after more than 18 
months.
Figure 6
Histological and immunohistochemical analysis data for biopsies  obtained from asymptomatic patients only Histological and immunohistochemical analysis data for biopsies 
obtained from asymptomatic patients only (n = 47). The biopsies were 
divided into those taken before (n = 41) or after (n = 6) the cutoff point 
of 18 months post Hyalograft® C Autograft implantation. Six biopsies 
were taken from asymptomatic patients longer than 18 months after 
surgery. Results showed that five out of six consisted primarily of hya-
line cartilage (83.3%); only one biopsy contained mixed tissue (17.7%).
Figure 7
Direction of tissue maturation in a biopsy classified as mixed Direction of tissue maturation in a biopsy classified as mixed. Gly-
cosaminoglycan (safranin-O) staining from a patient with mixed tissue 
18 months after implantation with Hyalograft® C Autograft. Arthritis Research & Therapy    Vol 10 No 6    Brun et al.
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Conclusion
Additional investigations will aim to identify the relationship
between a good clinical outcome and patient symptomatol-
ogy. This knowledge would help us to understand how to mod-
ulate and optimize natural cartilage turnover in adults, and how
to improve the clinical outcome of the engineered cartilage
implantation procedure.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
PB carried out the analytical approach, data collection and
analysis, and the write up. SCD carried out the data collection
and analysis. BZ carried out the data collection and analysis.
RC carried out the patient recruitment and application of clas-
sification criteria. APH carried out the patient recruitment, the
review of the manuscript, and supervision. GA carried out the
development of the protocol, the analytical approach, the
review of the manuscript and supervision.
Acknowledgements
The authors would like to thank Dr Gian Luca De Salvo of the Clinical 
Trials and Biostatistics Unit, Istituto Oncologico Veneto, Padova, Italy for 
his assistance with the statistical analysis.
References
1. Caplan AI, Elyaderami M, Mochizuki Y, Wakitini S, Goldberg VM:
Principles of cartilage repair and regeneration.  Clin Orthop
Relat Res 1997, 342:254-269.
2. Hunziker EB: Articular cartilage repair: basic science and clini-
cal progress. A review of the current status and prospects.
Osteoarthritis Cartilage 2002, 10:432-463.
3. Minas T, Nehrer S: Current concepts in the treatment of articu-
lar cartilage defects.  Orthopedics 1997, 20:525-538.
4. Simon TM, Jackson DW: Articular cartilage: injury pathways and
treatment options.  Sports Med Arthrosc 2006, 14:146-154.
5. Brittberg M, Lindhal A, Nilsson A, Ohlsson C, Isaksson O, Peter-
son L: Treatment of deep cartilage defects in the knee with
autologous chondrocyte transplantation.  N Engl J Med 1994,
331:889-895.
6. Peterson L, Minas T, Brittberg M, Nilsson A, Sjogren-Jansson E,
Lindahl A: Two- to 9-year outcome after autologous chondro-
cyte transplantation of the knee.  Clin Orthop 2000,
374:212-234.
7. Richardson JB, Caterson B, Evans EH, Ashton BA, Roberts S:
Repair of human articular cartilage after implantation of autol-
ogous chondrocytes.  J Bone Joint Surg Br 1999,
81:1064-1068.
8. Wasiak J, Clar C, Villanueva E: Autologous cartilage implanta-
tion for full thickness articular cartilage defects of the knee.
Cochrane Database Syst Rev 2006, 3:CD003323.
9. Campoccia D, Doherty P, Radice M, Brun P, Abatangelo G, Wil-
liams DF: Semisynthetic resorbable materials from hyaluronan
esterification.  Biomaterials 1998, 19:2101-2127.
10. Aigner J, Tegeler J, Hutzler P, Campoccia D, Pavesio A, Hammer
C, Kastenbauer E, Naumann A: Cartilage tissue engineering
with novel non-woven structured biomaterial based on
hyaluronic acid benzyl ester.  J Biomed Mater Res 1998,
42:172-181.
11. Brun P, Abatangelo G, Radice M, Zacchi V, Guidolin D, Daga Gor-
dini D, Cortivo R: Chondrocyte aggregation and reorganization
into three-dimentional scaffolds.  J Biomed Mater Res 1999,
46:337-346.
12. Radice M, Brun P, Cortivo R, Scapinelli R, Bataillard C, Abatangelo
G:  Hyaluronan-based biopolymers as delivery vehicles for
bone-marrow-derived mesenchymal progenitors.  J Biomed
Mater Res 2000, 50:101-109.
13. Grigolo B, Lisignoli G, Piacentini A, Fiorini M, Gobbi P, Mazzotti G,
Duca M, Pavesio A, Facchini A: Evidence for re-differentiation of
human chondrocytes grown on a hyaluronan-based biomate-
rial (HYAFF-11): molecular, immunohistochemical and
ultrastructural analysis.  Biomaterials 2002, 23:1187-1195.
14. Girotto D, Urbani S, Brun P, Renier D, Barbucci R, Abatangelo G:
Tissue-specific gene expression in chondrocytes grown on
three-dimensional hyaluronic acid scaffolds.  Biomaterials
2003, 24:3265-3275.
15. Pavesio A, Abatangelo G, Torrione A, Brocchetta D, Hollander A,
Kon E, Torasso F, Zanasi S, Marcacci M: Hyaluronan-based scaf-
folds (hyalograftC) in the treatment of knee cartilage defects:
preliminary clinical findings.  Novartis Found Symp 2003,
249:73-83.
16. Marcacci M, Berruto M, Brocchetta D, Delcogliano A, Ghinelli D,
Gobbi A, Kon E, Pederzin L, Rosa D, Sacchetti GL, Stefani G,
Zanasi S: Articular cartilage engineering with Hyalograft C: 3-
year clinical results.  Clin Orthop Relat Res 2005, 435:96-105.
17. Dickinson SC, Sims TJ, Pittarello L, Soranzo C, Pavesio A, Hol-
lander AP: Quantitative outcome measures of cartilage repair
in patients treated by tissue engineering.  Tissue Eng 2005,
11:277-287.
18. Hollander AP, Dickinson SC, Sims TJ, Brun P, Cortivo R, Kon E,
Marcacci M, Zanasi S, Borrione A, De Luca C, Pavesio A, Soranzo
C, Abtangelo G: Maturation of tissue engineered cartilage
implanted in injured and osteoarthritic human knees.  Tissue
Eng 2006, 12:1787-1798.
19. Sandell LJ, Morris N, Robbins JR, Goldring M: Alternatively
spliced type II procollagen mRNAs define distinct populations
of cells during vertebral development: differential expression
of the amino-propeptide.  J Cell Biol 1991, 114:1307-1319.
20. Tognana E, Chen F, Padera RF, Leddy HA, Christensen SE, Guilak
F, Vujak-Novakocic G, Freed LE: Adjacent tissues (cartilage,
bone) affect the functional integration of engineered calf carti-
lage in vitro.  Osteoarthritis Cartilage 2005, 13:129-138.
21. Brun P, Panfilo S, Daga Gordini D, Cortivo R, Abatangelo G: The
effect of hyaluronan on CD44-mediated proliferation of normal
and hydroxyl radical-damaged chondrocytes.  Osteoarthritis
Cartilage 2003, 11:208-216.
22. Kujawa MJ, Caplan AI: Hyaluronic acid bonded to cell-surface
stimulates chondrogenesis in stage 24 limb mesenchyme cell
cultures.  Dev Biol 1986, 114:504-518.
23. Toole BP: Hyaluronan in morphogenesis.  J Intern Med 1997,
242:35-40.